MedTech, Fitness Devices, Non-Invasive Spine Care

XYMF1D - Next Generation MedTech and Fitness Devices for Non-Invasive Spine Care

Broker is pleased to introduce an innovative medical equipment developer, manufacturer, and distributor of non-invasive spine care products for sale. The Company’s current flagship product is a patented, FDA-cleared multi-purpose therapeutic device for the treatment of patients suffering from severe low back pain and sciatica due to protruding or herniated intervertebral discs, acute facet problems, and/or degenerative disc disease. This medical device is utilized by Pain Management Centers, Orthopedic Hospitals, Sports Medicine, Physical Therapists, and Chiropractors in over 14 countries.

The Company’s MedTech Device focuses on the alleviation of back pain. The growing prevalence of chronic conditions is one of the key aspects anticipated to contribute to the market’s growth in Pain Management. The issues of musculoskeletal conditions, such as osteoarthritis, orthopedic degenerative diseases, arthritis, and rheumatoid arthritis, are rising significantly. This has increased the prevalence of chronic pain in these people and the incapability to carry out everyday chores. The CDC expects around 35 million individuals to be limited in their usual activities because of arthritis by 2040. Additionally, the sports and fitness industry in the U.S. is also impacted significantly by lower back pain, as approximately 20% of all injuries involve lower back and neck injuries. Certain sports experience a higher number of back and neck injuries as compared to others. The pain management device industry has experienced increased demand in recent years and is expected to continue to grow as the median age of the U.S. population increases.

The company is in the process of developing three next-generation non-invasive spine care products with patents pending, which are intended to significantly impact physical therapy, sports medicine, fitness, and the wellness sectors. The Company’s current flagship medical device is being updated for lower production costs, yielding higher margins and enhanced software. The software will have machine learning (AI) where data points of treatment will be entered and it will automate the next level of treatments. The current version of the device has been utilized during many sporting events for nearly 5 years by the PGA/USGA for the purpose of the USOPEN.

The Company has engaged with professional athletes, athletic trainers, physical therapists and medical doctors of teams involving NFL, NHL, NBA, MLB and USTA. The next generation fitness technologies device will improve athletic health and performance, injury recovery, and facilitate injury prevention.

The Company is ending its pre-revenue stage and has begun marketing its FDA-cleared therapeutic device. Organizational infrastructure is being built out and managed along with a domestic and international sales pipeline for growth. The sales of its current device are “proof of concept” for the development and launch of the Next Generation of products. The market segments and channels of distribution are very wide, with expected coverage in hospitals, clinics, physical therapy settings, and all areas of sports and fitness, as well as high-traffic areas of malls and airports. Within 3 years the Company is forecasting to generate $100 million in Revenues at a 38% EBITDA margin.

The Company is seeking $10 million of growth capital for the development